GSK Investigational Site

Prešov 081 81

0 studies enrolling now · 10 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Epilepsy, Pulmonary Disease, Chronic Obstructive, Purpura, Thrombocytopaenic, Idiopathic, Rhinitis, Allergic, Perennial

Studies at this site

• Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis — Stopped early
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag — Completed
• Pediatric Epilepsy Study in Subjects 1-24 Months — Completed
• A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis — Completed
• Pediatric Epilepsy Trial in Subjects 1-24 Months — Completed